|Day Low/High||55.98 / 58.12|
|52 Wk Low/High||53.45 / 103.91|
Jim Cramer says many stocks already reflect the worst-case scenarios, and that means he sees a lot of upside potential.
Jim discusses Darden's quarter and our decision to exit the position, Cimarex, Raytheon, 3M, and answers a question about the Bullpen!
The stock market continued its downward decline Tuesday amid fresh fears over a trade war with China.
Jim Cramer weighs in on Baidu.com, Momo, Praxair, Intrexon, Verizon, CenturyLink, ICU Medical and more.
Jim Cramer says we need stocks that are in sync with the global gloom and can be bought when we feel gloomy, which is pretty much every day.
We review Alphabet's investment in JD.Com and how OPEC's meeting could affect oil holdings in the portfolio.
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Cimarex Energy Co has taken over the #113 spot from Williams Cos Inc , according to ETF Channel. Below is a chart of Cimarex Energy Co versus Williams Cos Inc plotting their respective rank within the S&P 500 over time (XEC plotted in blue; WMB plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
Our small sale will also help replenish our coffers for use in future buys.
Jim discusses our Salesforce buy, Eli Lilly, UnitedHealth and Cimarex and also answers a club member's question!
Jim Cramer weighs in on Automatic Data Processing, ADT, Discovery Communications, Abiomed, L Brands and more.
Markets look calm, but we're seeing some extraordinary breakouts, says Jim Cramer.
We are taking advantage of share weakness to add to portfolio holdings of this oil play.
Jim discusses a Cimarex upgrade, Eli Lilly receiving positive attention, Microsoft and gaming, Facebook, and answers a club member's question on PepsiCo!
Jim provides his takeaways from The Deal Corporate Governance Conference, answers a question on Kohl's and discusses a Microsoft opportunity.
We view Cimarex's earnings as disconnected from the current stock price.
Jim discusses trade tariffs and how it affects the market, Alphabet and GDPR, and answers a member's question on 3M.
U.S. stocks regained most of the previous day's losses Wednesday, as concerns over Italy's political crisis eased.
We're holding out for better prices on JPMorgan, Schlumberger and other portfolio names, but you might not want to.
The stock is down some 3.5% on lower oil prices, but we think that's an overreaction.
From Netflix to Kraft Heinz, these names look good.
Jim Cramer weighs in on Royal Caribbean, Allergan, Tyson Foods, Carrizo Oil & Gas, Valeant Pharmaceuticals, Okta, CRISPR Therapeutics and more.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.